Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs.

Journal of pharmaceutical sciences·2012

Same author

Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.

Advanced drug delivery reviews·2011

Same author

In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol.

Journal of controlled release : official journal of the Controlled Release Society·2008

Same author

Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs.

Journal of controlled release : official journal of the Controlled Release Society·2006

Same author

Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin.

Pharmaceutical research·2004

Same author

Nanosizing: a formulation approach for poorly-water-soluble compounds.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2003

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

Drug nanoparticles: formulating poorly water-soluble compounds.

Elaine M Merisko-Liversidge¹, Gary G Liversidge

¹Elan Drug Technologies, King of Prussia, Pennsylvania 19406, USA. Elaine.liversidge@elan.com

Toxicologic Pathology

|March 14, 2008

Summary

Pure drug nanoparticles offer a novel solution for formulating poorly soluble compounds, improving drug delivery and enabling dose escalation for toxicological studies. This approach enhances bioavailability and exposure across various administration routes.

More Related Videos

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

Published on: November 14, 2015

Related Experiment Videos

Last Updated: Jul 6, 2026

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

A 'Plug and Play' Method to Create Water-dispersible Nanoassemblies Containing an Amphiphilic Polymer, Organic Dyes and Upconverting Nanoparticles

Published on: November 14, 2015

Area of Science:

Pharmaceutical Sciences
Drug Delivery
Nanotechnology

Background:

Over 40% of compounds from screening are poorly water-soluble, posing formulation challenges.
Conventional methods struggle with these compounds, leading to performance issues.
Pure drug nanoparticles represent an emerging drug delivery strategy.

Purpose of the Study:

To present nanoparticle dispersions as a viable formulation strategy for poorly water-soluble compounds.
To highlight the benefits of drug nanoparticles in drug discovery and toxicology.
To demonstrate the versatility of nanoparticulate formulations.

Main Methods:

Formulating pure drug nanoparticles using water and GRAS excipients.
Characterizing nanoparticle dispersions for stability and particle size (mean diameter < 1 micron).
Evaluating the potential for post-processing into solid dosage forms.

Main Results:

Nanoparticle dispersions are stable with acceptable shelf-life.
Drug nanoparticles improve bioavailability and enhance drug exposure.
Formulations can be developed with milligram quantities of drug substance.

Conclusions:

Nanoparticulate formulation is a versatile and increasingly realized approach for poorly water-soluble drugs.
This strategy facilitates drug screening, analog identification, and toxicological dose escalation.
The method offers a commercially viable formulation route for challenging compounds.